Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial

被引：0
|
作者：
Xiao, Chunyan [1 ]
Ding, Yao [1 ]
Zeng, Chensi [1 ]
Zhang, Lingqian [1 ]
Guo, Bingling [1 ]
Nan, Yingyu [1 ]
Liu, Yao [1 ]
机构：
[1] Chongqing Univ, Canc Hosp, Dept Hematol Oncol, Chongqing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181337
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] An open-label, single-center, phase II, single-arm trial of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma
    Xie, Y.
    Mi, L.
    Zheng, W.
    Ping, L.
    Lin, N.
    Tu, M.
    Zhang, C.
    Ying, Z.
    Liu, W.
    Deng, L.
    Wu, M.
    Wang, X.
    Zhu, J.
    Song, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S652 - S652
  • [22] Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
    Kim, Seok Jin
    Yoon, Dok Hyun
    Kang, Hye Jin
    Kim, Jin Seok
    Park, Seong Kyu
    Kim, Hyo Jung
    Lee, Jeeyun
    Ryoo, Baek-Yeol
    Ko, Young Hyeh
    Huh, Jooryung
    Yang, Woo Ick
    Kim, Hee Kyung
    Min, Soo Kee
    Lee, Seung-Sook
    Do, In-Gu
    Suh, Cheolwon
    Kim, Won Seog
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (17) : 3223 - 3231
  • [23] Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
    Wang, Wei
    Zhang, Wei
    Su, Li-ping
    Liu, Li-hong
    Gao, Yu-huan
    Wang, Quan-shun
    Su, Hang
    Song, Yu-qin
    Zhang, Hui-lai
    Shen, Jing
    Jing, Hong-mei
    Wang, Shu-ye
    Cen, Xi-nan
    Liu, Hui
    Liu, Ai-chun
    Li, Zeng-jun
    Luo, Jian-min
    He, Jian-xia
    Wang, Jing-wen
    O'Connor, O. A.
    Zhou, Dao-bin
    ANNALS OF HEMATOLOGY, 2024, : 3061 - 3069
  • [24] Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis
    Iino, Masaki
    Sato, Tomoya
    Nakadate, Ayato
    Onuki, Tomoya
    Takayama, Nobuyuki
    ANNALS OF HEMATOLOGY, 2022, 101 (10) : 2351 - 2352
  • [25] Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis
    Masaki Iino
    Tomoya Sato
    Ayato Nakadate
    Tomoya Onuki
    Nobuyuki Takayama
    Annals of Hematology, 2022, 101 : 2351 - 2352
  • [26] Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
    Chen, Suning
    Xie, Jundan
    Yang, Xiaofei
    Shen, Hongjie
    Cen, Jiannong
    Yao, Li
    Hu, Xiaohui
    Wu, Qian
    Zhang, Jingren
    Qiu, Hongchun
    Tang, Xiaowen
    Sun, Aining
    Xue, Shengli
    Wang, Ying
    Qiu, Huiying
    Wu, Depei
    BLOOD, 2021, 138
  • [27] First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant
    d'Amore, Francesco
    da Silva, Maria Gomes
    Leppa, Sirpa
    Relander, Thomas
    Pezzutto, Antonio
    Lauritzsen, Grete F.
    Weidmann, Eckhart
    Van Gelder, Michel
    Merup, Mats
    Hagberg, Hans
    Fagerli, Unn-Merete
    Brown, Peter de Nully
    Hansen, Per Boye
    Mariz, Jose Mario
    Jankovska, Milada
    Walewski, Jan
    Doorduijn, Jeanette
    Van Hoof, Achiel
    Christiansen, Ilse
    Jyrkkio, Sirkku
    Kluin-Nelemans, J. C.
    Kooy, Marinus van Marwijk
    Fijnheer, Rob
    Stevens, Wendy
    Zijlstra, Josee
    Bohmer, L.
    Lugtenburg, P. J.
    Grube, Matthias
    Prochazka, Vit
    Salek, David
    Greil, Richard
    Trumper, Lorenz
    Wulf, Gerald
    Altmann, Bettina
    Ziepert, Marita
    Loeffler, Markus
    Jantunen, Esa
    Hopfinger, Georg
    Van den Neste, Eric
    Toldbod, Helle
    BLOOD, 2011, 118 (21) : 1755 - 1755
  • [28] Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial
    Xu, Wei
    Xia, Yi
    Wang, Li
    Ding, Kaiyang
    Zhu, Huayuan
    Hu, Maogui
    Yin, Hua
    Wu, Jiazhu
    Shen, Haorui
    Liang, Jin-Hua
    Li, Jianyong
    BLOOD, 2021, 138
  • [29] Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial
    Yang, Tao
    Li, Jun
    Zhang, Wenjun
    Guo, Bingling
    Hu, Chongling
    Quan, Xi
    Zeng, Chensi
    Ding, Yao
    Huang, Dehong
    Xiao, Chunyan
    Liu, Jun
    Wu, Jing
    Wang, Chaoyu
    Liang, Xiping
    Zhang, Lingqian
    Yang, Zailin
    Liang, Shunsi
    Hu, Renzhi
    Liu, Tingting
    Li, Qiying
    Li, Jieping
    Nan, Yingyu
    Xiang, Ying
    Liu, Yao
    BLOOD, 2022, 140 : 9540 - 9541
  • [30] Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study
    Cao, Xin-Xin
    Li, Jian
    Zhao, Ai-Lin
    He, Tian-Hua
    Gao, Xue-Min
    Cai, Hua-Cong
    Zhang, Lu
    Zhang, Yan
    Feng, Jun
    Zhu, Tie-Nan
    Niu, Na
    Sun, Jian
    Liang, Zhi-Yong
    Duan, Ming-Hui
    Zhou, Dao-bin
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) : E235 - E238
12345